ING Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-780,139
Closed -$138M 421
2020
Q1
$138M Buy
780,139
+755,908
+3,120% +$142M 5.91% 4
2019
Q4
$4.63M Buy
24,231
+2,468
+11% +$445K 0.14% 114
2019
Q3
$3.66M Buy
+21,763
New +$3.55M 0.09% 149
2019
Q2
Sell
-46,567
Closed -$6.82M 872
2019
Q1
$6.82M Buy
46,567
+4,596
+11% +$666K 0.15% 101
2018
Q4
$5.61M Sell
41,971
-1,481
-3% -$243K 0.12% 119
2018
Q3
$8.28M Buy
43,452
+9,247
+27% +$1.7M 0.14% 105
2018
Q2
$5.7M Sell
34,205
-1,045
-3% -$168K 0.11% 113
2018
Q1
$5.93M Buy
35,250
+16,727
+90% +$2.81M 0.11% 115
2017
Q4
$3.03M Sell
18,523
-19,065
-51% -$3.42M 0.05% 178
2017
Q3
$7.7M Buy
37,588
+19,896
+112% +$4.63M 0.15% 111
2017
Q2
$4.3M Buy
+17,692
New +$4.16M 0.08% 142
2013
Q3
Sell
-1,986
Closed -$251K 780
2013
Q2
$251K Buy
+1,986
New +$225K ﹤0.01% 629

Other funds holding AGN

ING Group's AGN Position: Q2 2020 in Review

ING Group sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 780,139 shares — an estimated $138M sold.

ING Group first reported a position in AGN in Q2 2013 and held it in 12 quarters. The position peaked at $138M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • ING Group reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • ING Group sold 780,139 Allergan plc shares in Q2 2020, an estimated $138M.
  • ING Group first reported a position in Allergan plc in Q2 2013 and held it in 12 quarters.
  • ING Group's Allergan plc position peaked at $138M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on ING Group's 13F filing for Q2 2020, filed 13 Aug 2020.